Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

Fewer than 10% of dermatology patients who were seen virtually during the COVID pandemic said they would not use teledermatology again—and only 7% said they’d not recommend telehealth to a friend.

Almost a quarter of families would have balked before bringing an ill or injured child to the emergency department last spring, when COVID-19’s initial surge was underway in the U.S.

Google searches for “telehealth” have fallen far since peaking in March 2020. However, the term is plateauing at a rate that’s 320% higher than in pre-pandemic times.

The idea is to head off serious gathering threats without getting thrown off the scent by strains unlikely to proliferate.

AI melanoma detectors that equaled or bettered dermatologists in clinical trials have stumbled on the way to the real world of patient care. 

Another quick field check has found the federal rule requiring hospitals to show their prices for shoppable services meeting with only spotty compliance since it went into effect Jan. 1.

Fifteen-hospital McLaren Health Care has agreed to pay $7.75 million for illegally distributing prescription painkillers. 

Primary care practices battling burnout would do well to build capacity for adapting to change—taking charge of volatility rather than reacting to it—especially in times of widespread crisis.

The NIH, FDA and Bill and Melinda Gates Foundation are working with a San Francisco startup whose calling card is an AI-enabled engine that renders patient data unidentifiable by reproducing it in synthetic versions.